Literature DB >> 23113809

Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders.

Jodi Heaps1, Victor Valcour, Thep Chalermchai, Robert Paul, Somprartthana Rattanamanee, Umaporn Siangphoe, Pasiri Sithinamsuwan, Parnsiri Chairangsaris, Samart Nidhinandana, Somporn Tipsuk, Duanghathai Suttichom, James Fletcher, Cecilia Shikuma, Jintanat Ananworanich.   

Abstract

International studies of HIV-associated neurocognitive disorder (HAND) are needed to determine the viral and host factors associated with cognitive impairment particularly as more than 80% of HIV+ subjects reside in resource-limited settings. Recent diagnostic nomenclature of HAND requires comparison of cognitive performance specifically to local normative data. To evaluate this need for local norms, we compared normative data obtained locally in Thailand to Western norms. The current study examined cognitive performance in 477 seronegative Thai participants (male = 211, female = 266) who completed a battery of tests sensitive to cognitive changes in HIV. The cohort was divided into three age brackets (20-34; 35-49; 50-65 years) and four educational levels (no education or primary education, less than secondary certificate, high-school/associates degree, bachelor's degree or greater). The Thai cohort was compared (using analysis of covariance, ANCOVA) on a number of measures to a seronegative US cohort (n = 236; male = 198, female = 38) to examine cultural differences in performance. Normative data are provided with age and education stratification. The Thai and US groups performed significantly differently on all neuropsychological measures with the exception of verbal fluency. The Thai group performed better on measures of verbal learning (p < .001) and memory (p < .001) and measures of psychomotor speed (p < .001). Education was a more powerful predictor of performance in the Thai cohort than in the US group. These results highlight the continued need for the development of normative data within local populations. The use of Western norms as a comparison group could lead to inaccurate identification of HAND in culturally distinct groups.

Entities:  

Mesh:

Year:  2012        PMID: 23113809      PMCID: PMC3682786          DOI: 10.1080/13803395.2012.733682

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  16 in total

1.  Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine.

Authors:  Udaykumar Ranga; Raj Shankarappa; Nagadenahalli B Siddappa; Lakshmi Ramakrishna; Ramalingam Nagendran; Marthandan Mahalingam; Anita Mahadevan; Narayana Jayasuryan; Parthasarathy Satishchandra; Susarla K Shankar; Vinayaka R Prasad
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Normative data on cross-cultural neuropsychological tests obtained from Mandarin-speaking adults across the life span.

Authors:  Shiao-Ling Judy Hsieh; Christopher D Tori
Journal:  Arch Clin Neuropsychol       Date:  2007-02-12       Impact factor: 2.813

3.  The effect of African-American acculturation on neuropsychological test performance in normal and HIV-positive individuals. The HIV Neurobehavioral Research Center (HNRC) Group.

Authors:  J J Manly; S W Miller; R K Heaton; D Byrd; J Reilly; R J Velasquez; D P Saccuzzo; I Grant
Journal:  J Int Neuropsychol Soc       Date:  1998-05       Impact factor: 2.892

4.  Demographically corrected norms for the California Verbal Learning Test.

Authors:  M A Norman; J D Evans; W S Miller; R K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2000-02       Impact factor: 2.475

5.  Normative data stratified by age and education for the Neuropsychological Screening Battery for Hispanics (NeSBHIS): Initial report.

Authors:  M O Pontón; P Satz; L Herrera; F Ortiz; C P Urrutia; R Young; L F D'Elia; C J Furst; N Namerow
Journal:  J Int Neuropsychol Soc       Date:  1996-03       Impact factor: 2.892

6.  Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96).

Authors:  P Satishchandra; A Nalini; M Gourie-Devi; N Khanna; V Santosh; V Ravi; A Desai; A Chandramuki; P N Jayakumar; S K Shankar
Journal:  Indian J Med Res       Date:  2000-01       Impact factor: 2.375

7.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Authors:  R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

8.  WHO Neuropsychiatric AIDS study, cross-sectional phase I. Study design and psychiatric findings.

Authors:  M Maj; R Janssen; F Starace; M Zaudig; P Satz; B Sughondhabirom; M A Luabeya; R Riedel; D Ndetei; H M Calil
Journal:  Arch Gen Psychiatry       Date:  1994-01

9.  Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort.

Authors:  V Valcour; C Shikuma; B Shiramizu; M Watters; P Poff; O Selnes; P Holck; J Grove; N Sacktor
Journal:  Neurology       Date:  2004-09-14       Impact factor: 9.910

10.  HIV DNA and dementia in treatment-naïve HIV-1-infected individuals in Bangkok, Thailand.

Authors:  Bruce Shiramizu; Silvia Ratto-Kim; Pasiri Sithinamsuwan; Samart Nidhinandana; Sataporn Thitivichianlert; George Watt; Mark deSouza; Thippawan Chuenchitra; Suchitra Sukwit; Suwicha Chitpatima; Kevin Robertson; Robert Paul; Cecilia Shikuma; Victor Valcour
Journal:  Int J Med Sci       Date:  2006-12-06       Impact factor: 3.738

View more
  13 in total

1.  Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.

Authors:  Michael J Peluso; Victor Valcour; Jintanat Ananworanich; Pasiri Sithinamsuwan; Thep Chalermchai; James L K Fletcher; Sukalya Lerdlum; Nitiya Chomchey; Bonnie Slike; Napapon Sailasuta; Magnus Gisslén; Henrik Zetterberg; Serena Spudich
Journal:  J Infect Dis       Date:  2015-05-20       Impact factor: 5.226

2.  Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand.

Authors:  Jodi M Heaps; Pasiri Sithinamsuwan; Robert Paul; Sukalaya Lerdlum; Mantana Pothisri; David Clifford; Somporn Tipsuk; Stephanie Catella; Edgar Busovaca; James L K Fletcher; Benjamin Raudabaugh; Silvia Ratto-Kim; Victor Valcour; Jintanat Ananworanich
Journal:  J Neurovirol       Date:  2015-01-21       Impact factor: 2.643

3.  Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND.

Authors:  Thep Chalermchai; Victor Valcour; Pasiri Sithinamsuwan; Suteeraporn Pinyakorn; David Clifford; Robert H Paul; Somporn Tipsuk; James L K Fletcher; Victor Degruttola; Silvia Ratto-Kim; Nicholas Hutchings; Cecilia Shikuma; Jintanat Ananworanich
Journal:  J Neurovirol       Date:  2013-03-13       Impact factor: 2.643

4.  Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.

Authors:  Napapon Sailasuta; Jintanat Ananworanich; Sukalaya Lerdlum; Pasiri Sithinamsuwan; James L K Fletcher; Somporn Tipsuk; Mantana Pothisri; Tanate Jadwattanakul; Supunnee Jirajariyavej; Thep Chalermchai; Stephanie Catella; Edgar Busovaca; Akash Desai; Robert Paul; Victor Valcour
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

Review 5.  The Impact of Antiretroviral Therapy on Neurocognitive Outcomes Among People Living with HIV in Low- and Middle-Income Countries (LMICs): A Systematic Review.

Authors:  Henry Ukachukwu Michael; Sasha Naidoo; Kofi Boamah Mensah; Suvira Ramlall; Frasia Oosthuizen
Journal:  AIDS Behav       Date:  2021-02

6.  Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy.

Authors:  Idil Kore; Jintanat Ananworanich; Victor Valcour; James L K Fletcher; Thep Chalermchai; Robert Paul; Jesse Reynolds; Somporn Tipsuk; Sasiwimol Ubolyam; Somprartthana Rattanamanee; Linda Jagodzinski; Jerome Kim; Serena Spudich
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

7.  HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cART.

Authors:  Tanya C Do; Stephen J Kerr; Anchalee Avihingsanon; Saowaluk Suksawek; Supalak Klungkang; Taweesak Channgam; Christoph C Odermatt; Wirach Maek-A-Nantawat; Kiat Ruxtungtham; Jintanat Ananworanich; Victor Valcour; Peter Reiss; Ferdinand W Wit
Journal:  J Virus Erad       Date:  2018-01-01

8.  Neurologic signs and symptoms frequently manifest in acute HIV infection.

Authors:  Joanna Hellmuth; James L K Fletcher; Victor Valcour; Eugène Kroon; Jintanat Ananworanich; Jintana Intasan; Sukalaya Lerdlum; Jared Narvid; Mantana Pothisri; Isabel Allen; Shelly J Krebs; Bonnie Slike; Peeriya Prueksakaew; Linda L Jagodzinski; Suwanna Puttamaswin; Nittaya Phanuphak; Serena Spudich
Journal:  Neurology       Date:  2016-06-10       Impact factor: 9.910

9.  HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

Authors:  Victor G Valcour; Jintanat Ananworanich; Melissa Agsalda; Napapon Sailasuta; Thep Chalermchai; Alexandra Schuetz; Cecilia Shikuma; Chin-Yuan Liang; Supunee Jirajariyavej; Pasiri Sithinamsuwan; Somporn Tipsuk; David B Clifford; Robert Paul; James L K Fletcher; Mary A Marovich; Bonnie M Slike; Victor DeGruttola; Bruce Shiramizu
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

10.  Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV.

Authors:  Victor G Valcour; Serena S Spudich; Napapon Sailasuta; Nittaya Phanuphak; Sukalaya Lerdlum; James L K Fletcher; Eugene D M B Kroon; Linda L Jagodzinski; Isabel E Allen; Collin L Adams; Peeriya Prueksakaew; Bonnie M Slike; Joanna M Hellmuth; Jerome H Kim; Jintanat Ananworanich
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.